Group Introduction
[Its Dual-Listed Companies] Joincare Pharmaceutical Group (Stock Code: 600380 GDR Code：JCARE) Livzon Pharmaceutical Group (Stock Code: 000513 Hong Kong Stock Code: 01513)
Health Yuan Hai Bin Pharmaceutical Co., Ltd.
Healthyuan Haibin Pharmaceutical Co., Ltd. Registered in 2018, with a registered capital of 500 million yuan, located in Pingshan District, Shenzhen. It was jointly established by Joincare Pharmaceutical Group Industry Co., Ltd. and Shenzhen Haibin Pharmaceutical Co., Ltd., covering an area of approximately 45,000 square meters ，with a construction area of approximately 11.7 square meters.
In 2021, it obtained the qualifications of "National High-tech Enterprise" and "Shenzhen Specialized, Refined, and New Small and Medium-sized Enterprise"; in 2022, it was approved as the "Guangdong Provincial Engineering Technology Research Center for Key Technologies and Innovative Applications in the Industrialization of Inhalation Preparations"; in 2024, it completed the filing of the "Guangdong Provincial Level II Pathogenic Microorganism Laboratory". In recent years, it has also obtained "Pingshan District Outstanding Contribution Industrial Enterprise Award", "Shenzhen Sponge City Exemplary Project", "Shenzhen Green Building Design Certification", "National Green Factory" and other certificates. It has passed the quality management system ISO9001, environmental management system ISO14001, occupational health and safety management system ISO45001, energy management system ISO5001, compliance management system certification GB/T35770-2022/IS037301, intellectual property management system GB/T29490 certification and obtained certificates. It has been authorized 55 patents, including 7 invention patents.
This company is an important pharmaceutical research and development and production base under the Healthyuan Group, with production lines for inhalation solutions, inhalation suspensions, inhalation powders, lyophilized powder injections （ microcrystalline ）、 small-volume injections (vials / nanocrystalline ), small-volume injections (pre-filled / nanocrystalline ), tablets and capsules dry powder suspensions (spray drying) and other multiple preparation production lines, main production lines have passed GMP compliance inspection. Main products include inhalation budesonide suspension 、 tobramycin inhalation solution 、 salmeterol fluticasone propionate inhalation powder 、 combination ipratropium bromide inhalation solution 、 ipratropium bromide inhalation solution 、 terbutaline sulfate nebulized inhalation solution, fluticasone propionate nebulized inhalation suspension, formoterol fumarate inhalation solution 、 salbutamol hydrochloride inhalation solution etc. 。 Research and development of innovative drugs include mavacasap, new small molecule glucocorticoid drug 、 inhalation PDE4 inhibitor etc. more than 10 varieties.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.